Newstral
Article
Financial Times on 2022-07-30 14:06
AstraZeneca PLC: AstraZeneca to double number of countries where US biotech arm sells rare disease drugs
Related news
- Countries halting AstraZeneca vaccinevanguardngr.com
- AstraZeneca to buy biotech firmnwaonline.com
- LAutoimmune Disease Drug Market: Size, Growth, Facts, Figures and Trends 2021-2027 | Top Vendors : Abbott Laboratories, Roche, Eli Lilly, Pfizer, GlaxoSmithKline, AbbVie, Amgen, AstraZeneca plc, Briâ¦.liverpoolstudentmedia.com
- AstraZeneca PLC: Cancer drugs help AstraZeneca beat forecastsFinancial Times
- AstraZeneca PLC: AstraZeneca signs vaccine deal with China’s CanSinoFinancial Times
- AstraZeneca PLC: AstraZeneca settles heartburn drug lawsuits for $425mnFinancial Times
- FAstraZeneca PLC: AstraZeneca unveils successes in treatment of lung cancerft.com
- AstraZeneca PLC: AstraZeneca hails ‘clinically meaningful’ cancer drug trial resultsFinancial Times
- FAstraZeneca PLC: Cancer drug sales help AstraZeneca beat forecastsft.com
- Biotech: AstraZeneca to buy US biotech CinCor in $1.8bn dealFinancial Times
- AstraZeneca buying California biotech firm for $2.7Bbizjournals.com
- AstraZeneca buys US biotech firm CinCortimesofmalta.com
- FAstraZeneca backs $1bn China biotech fundft.com
- SSanta Monica biotech company acquired by AstraZenecasmdp.com
- FScandinavian countries keep AstraZeneca vaccine on holdft.com
- African countries temporarily suspend AstraZeneca vaccineDeutsche Welle Englisch
- FAstraZeneca uses AI to tackle neurological diseaseft.com
- AstraZeneca PLC: AstraZeneca raises forecasts after strong Covid and cancer drug salesFinancial Times
- FAstraZeneca PLC: AstraZeneca shareholders urged to oppose pay plan for CEO Soriotft.com